Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Guided Therapeutics Inc. (GTHP : OTC)
 
 • Company Description   
GUIDED THERAPEUTICS, Inc. is developing a rapid and painless test for the early detection of disease that leads to cervical cancer. The technology is designed to quickly eliminate false positive Pap and HPV results and discover cervical disease missed by existing tests. Unlike Pap and HPV tests, the device does not require a painful tissue sample and results are available immediately. GT also owns technology for measuring substances in interstitial fluid, a secondary circulatory system in the body that surrounds the cells.

Number of Employees: 8

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.45 Daily Weekly Monthly
20 Day Moving Average: 6,860 shares
Shares Outstanding: 27.57 (millions)
Market Capitalization: $12.30 (millions)
Beta: 0.67
52 Week High: $0.78
52 Week Low: $0.28
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -38.88% -31.16%
12 Week -21.72% -13.95%
Year To Date -23.10% 5.30%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5835 PEACHTREE CORNERS EAST SUITE B
-
NORCROSS,GA 30092
USA
ph: 770-242-8723
fax: 770-242-8639
info@guidedinc.com http://www.guidedinc.com
 
 • General Corporate Information   
Officers
Gene S. Cartwright - Chief Executive Officer; President; Acting Chief F
Michael C. James - Chairman and Director
Mark Faupel - Chief Operating Officer and Director
Richard P. Blumberg - Director
John E. Imhoff - Director

Peer Information
Guided Therapeutics Inc. (BJCT)
Guided Therapeutics Inc. (CADMQ)
Guided Therapeutics Inc. (APNO)
Guided Therapeutics Inc. (UPDC)
Guided Therapeutics Inc. (IMTIQ)
Guided Therapeutics Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 40171F501
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/21
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 27.57
Most Recent Split Date: 3.00 (0.00:1)
Beta: 0.67
Market Capitalization: $12.30 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 143.04
EPS Growth
vs. Year Ago Period: -50.00%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -91.67%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -4.82
ROA
03/31/22 - -102.51
12/31/21 - -100.82
09/30/21 - 31.80
Current Ratio
03/31/22 - 0.33
12/31/21 - 0.29
09/30/21 - 0.26
Quick Ratio
03/31/22 - -
12/31/21 - 0.19
09/30/21 - 0.15
Operating Margin
03/31/22 - -2,395.35
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -2,395.35
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -2,395.35
12/31/21 - -2,555.55
09/30/21 - 1,300.00
Book Value
03/31/22 - -0.40
12/31/21 - -0.90
09/30/21 - -0.88
Inventory Turnover
03/31/22 - 0.10
12/31/21 - 0.10
09/30/21 - -0.03
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©